SectorBiological Technology
Established Date--
Listing Date04/02/2000
ExchangeNASDAQ Stock Exchange
Full-time Employees81
Fiscal Year Ends31/12
Security TypeCommon stock
Office address3 Forbes Road, Lexington, Massachusetts 02421
Business
IntroductionAgenus Inc., founded in 1994, is a Delaware limited liability company. The company is a clinical-stage biotechnology company specializing in the development of therapies that activate the human immune system to fight cancer and infection. Their main clinical program is botensilimab, including monotherapy and combination therapy with balstilimab. They also have some clinical-stage immuno-oncology assets that can be used as stand-alone drugs or in combination with botensilimab and balstilimab.
